Mouse Anti-DSN1 Recombinant Antibody (2A7) (CBMAB-A0966-LY)

Wang, X., Lu, X., Wang, P., Chen, Q., Xiong, L., Tang, M., ... & Lin, J. (2022). SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner. Journal of translational medicine, 20(1), 1-18.

Li, F. N., Zhang, Q. Y., Li, O., Liu, S. L., Yang, Z. Y., Pan, L. J., ... & Dong, P. (2021). ESRRA promotes gastric cancer development by regulating the CDC25C/CDK1/CyclinB1 pathway via DSN1. International journal of biological sciences, 17(8), 1909.

Peng, Q., Wen, T., Liu, D., Wang, S., Jiang, X., Zhao, S., & Huang, G. (2021). DSN1 is a prognostic biomarker and correlated with clinical characterize in breast cancer. International Immunopharmacology, 101, 107605.

Li, Q., Liang, J., & Chen, B. (2020). Identification of CDCA8, DSN1 and BIRC5 in regulating cell cycle and apoptosis in osteosarcoma using bioinformatics and cell biology. Technology in Cancer Research & Treatment, 19, 1533033820965605.

Sun, C., Huang, S., Ju, W., Hou, Y., Wang, Z., Liu, Y., ... & He, X. (2018). Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma. Human pathology, 81, 113-120.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Isotype control